Articles by James Calloway
Stellantis Plunges on €22.2B EV Charge, Gigafactory Halt
Stellantis shares dropped sharply after announcing a major strategic reset, including a €22.2 billion impairment and shelving European battery plant projects.
Pagaya Shares Surge 10% in Premarket Ahead of Q4 Earnings and 2026 Guidance
Pagaya Technologies stock jumped approximately 10% to $20.50 in premarket trading Monday as investors anticipate the company's fourth-quarter results and its financial outlook for 2026.
DBS Shares Slide on Q4 Profit Shortfall, 2026 Outlook Cautious
DBS Group shares fell nearly 2% after reporting a 10% drop in fourth-quarter profit, missing estimates. The bank flagged a softer 2026 net profit outlook amid narrowing interest margins.
Diageo Gains on Sterling Weakness Ahead of Interim Results
Diageo shares rose 0.6% in London trading as a weaker pound boosted the outlook for the spirits giant's overseas earnings. Investors are positioning for the company's interim results due February 25.
Barclays Gains Ahead of Key Earnings Report as Banking Sector Shows Strength
Barclays shares advanced 0.8% in early London trading ahead of its full-year results release Tuesday, with investors focused on cost guidance and capital returns. The broader FTSE 100 rose 0.3%, supported by financials.
BAE Systems Stock Advances on Buyback Activity Ahead of Key Earnings Report
BAE Systems shares gained 1.8% in early London trading following a fresh share repurchase disclosure. Investors now await the defense contractor's full-year results and 2026 outlook due February 18.
Rolls-Royce Advances Share Buyback Program Ahead of Key Financial Results
Rolls-Royce shares gained 2.4% in London trading as the company continued its £200 million share repurchase initiative, with investors anticipating full-year results and future capital return plans later this month.
BP Shares Dip Amid Oil Price Retreat; Investors Eye Annual Results and Capital Return Strategy
BP shares declined 0.6% in early London trading, tracking a drop in crude prices as U.S.-Iran talks eased supply concerns. Attention turns to the company's full-year results on Feb. 10 for clarity on shareholder returns and strategic direction.
SSE Shares Approach 52-Week High Amid Regulatory Scrutiny and Investment Focus
SSE shares gained 0.32% to 2,518p in early London trading, nearing a 52-week peak. Investors are monitoring regulatory decisions and the company's £1.8 billion network investment plan.
GSK Nears 52-Week Peak on COPD Drug Approval and U.S. Pricing Developments
GSK shares advanced 0.6% in London trading, approaching a 52-week high following EU approval for Nucala in COPD and amid U.S. drug discount initiatives. Insider trading activity and the upcoming ex-dividend date remain in focus.
South Korean Regulators Eye Stricter Crypto Oversight After Bithumb's $40 Billion Error
South Korea's financial watchdog is pushing for tighter cryptocurrency regulations following a major incident at exchange Bithumb, which mistakenly distributed over $40 billion in Bitcoin to users. Authorities are considering enhanced inspections and addressing systemic vulnerabilities.
British American Tobacco Shares Dip Ahead of Key Earnings Report
British American Tobacco shares edged lower in early London trading following a routine buyback update, underperforming the broader FTSE 100 as investors await crucial full-year results and 2026 guidance.